Back to search results

Phase Ib Clinical Study of Keynatinib

Abroad (travel likely)RecruitingPHASE1

Conditions

Lymphoma, B-Cell

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Yuankai Shi, PhD) · syuankaipumc@126.com · +86(010)-87788293
    Contact: Principal Investigator (Yuankai Shi, phD)
    Shengyu Zhou, phD (Sub-investigator)

  • Peking University Third Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Hongmei Jing, phD) · bysyjhm@sina.com · +8615611908428

  • Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Fangfang Lv, MD) · lvff80@163.com · +8618017312613
    Contact: Principal Investigator (Dongmei Ji, phD)
    Contact: Principal Investigator (Fangfang Lv, MD)

  • West China Hospital，Sichuan University, Chengdu, Sichuan, China

    Contact: Study coordinator (Liqun Zou, phD) · hxlcyxy@163.com · +8618980601027
Study leads

  • Dawei Zhang, phD

    Study Director

    Medolution Ltd.

View source on ClinicalTrials.gov(opens in a new tab)